Parallel Bio received approval from the United States Food and Drug Administration to test drug toxicity on human organoids instead of live animal trials

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.